CDCA2
Cell division cycle-associated protein 2
Also known as: CDCA2_HUMAN, PPP1R81, Repo-Man
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q69YH5
- Gene
- CDCA2
- Ensembl
- ENSG00000184661
- Chromosome
- 8
- Canonical length
- 1023 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a targeting subunit of the cell-cycle associated protein, protein phosphatase 1, with a role in targeting this protein to chromatin during anaphase. These two proteins comprise a phosphatase complex that is involved in nuclear envelope reformation and regulation of the DNA damage response. The encoded protein may also play a role in cancer progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Canonical amino-acid sequenceUniProt
1023 residues, UniProt reviewed canonical sequence.
>Q69YH5|CDCA2
1 MDANSKDKPP ETKESAMNNA GNASFILGTG KIVTPQKHAE LPPNPCTPDT FKSPLNFSTV
61 TVEQLGITPE SFVRNSAGKS SSYLKKCRRR SAVGARGSPE TNHLIRFIAR QQNIKNARKS
121 PLAQDSPSQG SPALYRNVNT LRERISAFQS AFHSIKENEK MTGCLEFSEA GKESEMTDLT
181 RKEGLSACQQ SGFPAVLSSK RRRISYQRDS DENLTDAEGK VIGLQIFNID TDRACAVETS
241 VDLSEISSKL GSTQSGFLVE ESLPLSELTE TSNALKVADC VVGKGSSDAV SPDTFTAEVS
301 SDAVPDVRSP ATPACRRDLP TPKTFVLRSV LKKPSVKMCL ESLQEHCNNL YDDDGTHPSL
361 ISNLPNCCKE KEAEDEENFE APAFLNMRKR KRVTFGEDLS PEVFDESLPA NTPLRKGGTP
421 VCKKDFSGLS SLLLEQSPVP EPLPQPDFDD KGENLENIEP LQVSFAVLSS PNKSSISETL
481 SGTDTFSSSN NHEKISSPKV GRITRTSNRR NQLVSVVEES VCNLLNTEVQ PCKEKKINRR
541 KSQETKCTKR ALPKKSQVLK SCRKKKGKGK KSVQKSLYGE RDIASKKPLL SPIPELPEVP
601 EMTPSIPSIR RLGSGYFSSN GKLEEVKTPK NPVKRKDLLR HDPDLHMHQG YDKYDVSEFC
661 SYIKSSSSLG NATSDEDPNT NIMNINENKN IPKAKNKSES ENEPKAGTDS PVSCASVTEE
721 RVASDSPKPA LTLQQGQEFS AGGQNAENLC QFFKISPDLN IKCERKDDFL GAAEGKLQCN
781 RLMPNSQKDC HCLGDVLIEN TKESKSQSED LGRKPMESSS VVSCRDRKDR RRSMCYSDGR
841 SLHLEKNGNH TPSSSVGSSV EISLENSELF KDLSDAIEQT FQRRNSETKV RRSTRLQKDL
901 ENEGLVWISL PLPSTSQKAK RRTICTFDSS GFESMSPIKE TVSSRQKPQM APPVSDPENS
961 QGPAAGSSDE PGKRRKSFCI STLANTKATS QFKGYRRRSS LNGKGESSLT ALERIEHNGE
1021 RKQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDCA2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.7
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- testis: 18 nTPM
- thymus: 11 nTPM
- tonsil: 6.3 nTPM
- bone marrow: 6.1 nTPM
- lymph node: 4.9 nTPM
- appendix: 2.4 nTPM
Single-cell type
- late primary spermatocytes: 109 nCPM
- monocyte progenitors: 74 nCPM
- erythrocyte progenitors: 64 nCPM
- early primary spermatocytes: 54 nCPM
- differentiating spermatogonia: 52 nCPM
- undifferentiated spermatogonia: 40 nCPM
Immune cell
- NK-cell: 0.6 nTPM
- T-reg: 0.4 nTPM
- memory B-cell: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- thalamus: 0.7 nTPM
- pons: 0.5 nTPM
- cerebellum: 0.3 nTPM
- medulla oblongata: 0.3 nTPM
- white matter: 0.3 nTPM
- basal ganglia: 0.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.43
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDCA2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDCA2 as an antibody target. Whether an autoantibody or antibody against CDCA2 could matter depends on whether native CDCA2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDCA2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CDCA2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...